The Elizabeth H. and James S. McDonnell III Genome Institute provides comprehensive genomic services to Washington University and the scientific community.
Leading the way in high-speed, comprehensive genomics.
We aim to improve the human condition by producing, studying and interpreting high-quality genome-based data that drives biological discoveries.
A Team of Experts
Li Ding, PhD, led a team that analyzed DNA from nearly 10,000 patient tumors across 33 cancer types. They found 300 genes that drive cancer, and more than half of the tumors analyzed had at least one mutation of clinical significance.
Over $1.3B in Research Funding
The McDonnell Genome Institute has received over $1.3 billion in research funding to inform future clinical work and help in the study, diagnosis and treatment of disease.
Latest News
Sequencing the future
Generous pledge from James and Elizabeth McDonnell accelerates the expansion of their namesake genome institute BY MARY LEE
Combating COVID-19
Medical school labs pivot to fight a common enemy
Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay
Fluidigm said on Thursday that it has received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.